Concepedia

Avery Rosegay

AR

Statistics

Publications

22

Citations

1.2K

H-Index

15

Active since

1963

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Avery Rosegay is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, biochemistry, and pharmacy.

Publications per year

1963–1997

22

Publications

22

Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.

S. Vickers, C A Duncan, I W Chen et al. · Drug Metabolism and Disposition · 1990 · 245 citations

, , +17

<b>Non-Steroid Anti-Inflammatory Agents</b>

T. Y. Shen, Thomas B. Windholz, Avery Rosegay et al. · Journal of the American Chemical Society · 1963 · 174 citations · Full text

, , +5

Absorption, tissue distribution, and excretion of tritium-labeled ivermectin in cattle, sheep, and rat

S H Chiu, Marilyn L. Green, Francis P. Baylis et al. · Journal of Agricultural and Food Chemistry · 1990 · 134 citations

, , +8

The metabolism of DuP 753, a nonpeptide angiotensin II receptor antagonist, by rat, monkey, and human liver slices.

Ralph A. Stearns, R R Miller, George A. Doss et al. · Drug Metabolism and Disposition · 1992 · 97 citations

, , +9

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

Robert S. Chang, T B Chen, Mark G. Bock et al. · Molecular Pharmacology · 1989 · 91 citations

, , +13

1–5 of 22